Genesis Therapeutics | LinkedIn (original) (raw)
``
Biotechnology Research
Burlingame, California 10,154 followers
Unifying AI and Biotech to accelerate the discovery of new medicines
About us
Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery. The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022) and Genentech (signed in 2020). Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. We are rapidly growing our team with a variety of openings on our machine learning, computational chemistry, and software teams (primarily located in the Bay Area) and our chemistry, biology, and clinical teams (primarily located in San Diego). To learn more about Genesis Therapeutics, or current employment opportunities, please visit our website.
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Burlingame, California
Type
Privately Held
Specialties
Deep Learning, Drug Discovery, Artificial Intelligence, and Drug Development
Locations
Employees at Genesis Therapeutics
Updates
-
10,154 followers
2w Edited
We’re thrilled to announce our collaboration with Gilead! Together, we’re combining forces to accelerate groundbreaking discoveries and push the boundaries of what’s possible in drug development. This partnership highlights the power of our AI platform, GEMS, and our shared commitment to creating innovative and breakthrough medicines for patients with high unmet medical need. Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies | Business Wirehttps://lnkd.in/g6d_gFBA - The Genesis team is excited to be attending #ICML2024 in Vienna this week, July 21-27. We’re proud to be sponsoring ML4LMS as well as the SPIGM Workshop where our Director of Machine Learning, Maruan Al-Shedivat, PhD, will be giving a talk on Generative Modeling in Drug Discovery. If you’re at ICML, we’d love to connect with you - if you would like to chat with a member of our technical team, sign up here: http://bit.ly/4dcTuiw
-
10,154 followers
7mo Edited
Yesterday, Genesis's CTO and co-founder Ben Sklaroff spoke at Biocom California about the potential of AI to unlock undruggable targets and help surface novel molecules that could become breakthrough therapies for patients. Learn more about how Genesis is pioneering generative and predictive AI for drug discovery here: https://lnkd.in/g_jdaiYN -
Founder and CEO at Genesis Therapeutics, Inc.
8mo
Enjoyed sitting down with John Carroll and an engaging group of panelists at the #WuxiGlobalForum this week at JPM. Thanks WuXi AppTec for the invite and opportunity to speak to how Genesis Therapeutics is pioneering AI-powered drug discovery to create breakthroughs for patients. - Next week, Genesis’ CEO, Dr. Evan Feinberg, PhD, will speak at the 2024 WuXi AppTec Global Forum alongside fellow industry leaders to discuss how platform solutions, such as Genesis’ AI-enabled drug discovery platform, are driving the development of medicines that improve the lives of patients living with difficult-to-treat disease. Learn more about the panel, “Delivering on Platform Solutions,” and the forum here: https://lnkd.in/ggbqGe2F
WuXi XPress: for WuXi news and R&D insights wxpress.wuxiapptec.com - Genesis’ CEO and co-founder Evan Feinberg sat down with a16z Bio + Health and Health’s Vijay Pande, PhD on this week’s episode of Bio Eats World to discuss AI in small-molecule drug design and the founding of Genesis, from Evan’s early days at Stanford to the company’s recent $200M series B. Listen to the podcast episode here: https://lnkd.in/g6-Zv-kQ
Advances in technology increasingly occur at the intersection of disciplines.Vijay Pande, PhD, recently spoke with Evan Feinberg, Founder and CEO of Genesis Therapeutics, about how he built a company that fosters collaboration between experts in complementary fields like biology, chemistry, and AI to supercharge discovery. Here’s how Evan does it at Genesis: 👉🏼 Engineers work hand-in-hand with biologists and chemists. Co-leads from complementary backgrounds partner on projects. 👉🏼 Created an internal platform called Nucleus which allows Genesis chemists to access the companies latest AI models. 👉🏼 Maintaining an approximate balance of 50% computational and 50% experimental scientists. The future of health will be driven by the synthesis of ideas at the intersections of expertise. Listen to Evan’s full episode on Bio Eats World here: https://lnkd.in/gdqZQZfK
Supercharging Discovery with Evan Feinberg | Andreessen Horowitz https://a16z.com
Join now to see what you are missing
Similar pages
- Structure Therapeutics Biotechnology Research South San Francisco, California
- CARGO Therapeutics Biotechnology Research San Carlos, California
- Kyverna Therapeutics Biotechnology Research Emeryville, California
- Xaira Therapeutics Biotechnology Research Brisbane, CA
- MapLight Therapeutics, Inc. Biotechnology Research Palo Alto, CA
- Abdera Therapeutics Biotechnology Research South San Francisco, California
- Vilya Biotechnology Research South San Francisco, CA
- Montara Therapeutics, Inc. Biotechnology Research San Francisco, California
- EditCo Bio Biotechnology Research Redwood City, California
- Genista Biosciences Biotechnology Research San Jose, California
Browse jobs
- Director of Reimbursement jobs 4,163 open jobs
- Chief Operating Officer jobs 32,856 open jobs
- Reimbursement Manager jobs 23,091 open jobs
- Health Director jobs 474,514 open jobs
- Strategic Account Manager jobs 24,959 open jobs
- Senior jobs 1,142,468 open jobs
- Executive Director jobs 64,552 open jobs
- Vice President Operations jobs 10,156 open jobs
- Associate Director jobs 156,364 open jobs
- Manager jobs 2,003,890 open jobs
- Analyst jobs 760,055 open jobs
- Head jobs 1,135,865 open jobs
- Investment Associate jobs 43,599 open jobs
- Director of Operations jobs 66,372 open jobs
- Director jobs 1,374,979 open jobs
- Machine Learning Engineer jobs 183,664 open jobs
- President jobs 91,996 open jobs
- Sales Director jobs 92,736 open jobs
- Account Manager jobs 152,491 open jobs
- Investment Analyst jobs 16,073 open jobs